Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Weekly Report Card

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Aug 14, 2021 9:27pm

129 Views

Post# 33706815

RE:RE:RE:RE:Weekly Report Card

Arrowstreet wasn't one of the 4 lead new investors mentioned to us. They were Soleus, Armistice, AIGH and Stonepine. Arrowstreet is a massive global equity firm with over $150bil. Great reputation. They research companies in depth and apply quantitative tools to build portfolios.

they have global small cap, the likely owner of THTX shares. Still could have bought in deal as a very tiny holding. They are generally pretty long term. Hopefully they come back in once it's big enough for them to actually trade in it and establish a big position. Good name to remember for the ATM at higher prices.

<< Previous

Bullboard Posts

Next >>

Buzz on the Bullboards: Markets recover after interest rate cut